Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution

Area of Science:

• Nanotechnology
• Pharmaceutical Sciences
• Oncology

Background:

• Paclitaxel (PTX) is a vital chemotherapeutic agent.
• Conventional PTX formulations face challenges with short circulation times and suboptimal biodistribution.
• Stealth liposomes offer potential for improved drug delivery systems.

Purpose of the Study:

• To prepare and characterize paclitaxel (PTX)-loaded stealth liposomes.
• To evaluate the in vitro release, pharmacokinetics, and biodistribution of PTX-loaded stealth liposomes.
• To assess the potential of stealth liposomes as a drug delivery vehicle for cancer chemotherapy.

Main Methods:

• Preparation of PTX-loaded stealth liposomes using the thin film hydration technique.
• Characterization of liposomes including morphology, size, and encapsulation efficiency.
• In vitro release studies, pharmacokinetic analysis, and biodistribution profiling in vivo.

Main Results:

• Spherical, uniformly sized stealth liposomes with high encapsulation efficiency (91.1 ± 4.3%) were successfully prepared.
• PTX-loaded stealth liposomes demonstrated favorable pharmacokinetics and biodistribution compared to free PTX.
• Stealth liposomes exhibited significantly prolonged circulation time (half-life of 34.2 h) versus conventional liposomes (13.7 h).

Conclusions:

• Stealth liposomes are a potent vehicle for paclitaxel delivery in cancer chemotherapy.
• The developed stealth liposomes represent a suitable platform for targeted liposomal PTX systems.
• This approach holds promise for enhancing the efficacy of cancer treatment.